Disrupting cellular memory to overcome drug resistance

• Published in: Nature communications 2023-11, Vol.14 (1), p.7130-7130, Article 7130
• Main Authors: Harmange, Guillaume, Hueros, Raúl A. Reyes, Schaff, Dylan L., Emert, Benjamin, Saint-Antoine, Michael, Kim, Laura C., Niu, Zijian, Nellore, Shivani, Fane, Mitchell E., Alicea, Gretchen M., Weeraratna, Ashani T., Simon, M. Celeste, Singh, Abhyudai, Shaffer, Sydney M.
• Format: Article
• Language: English
• Subjects: 1-Phosphatidylinositol 3-kinase; 13; 13/31; 38; 38/32; 45; 45/91; 631/208/199; 631/553/1745; 631/553/1833; 631/67/1059/2326; 631/67/1813/1634; Cell Differentiation - genetics; Drug resistance; Drug Resistance, Neoplasm; Gene expression; Humanities and Social Sciences; Melanoma; Modulators; multidisciplinary; Phosphatidylinositol 3-Kinases; Science; Science (multidisciplinary); Switching; Therapy; Transforming Growth Factor beta; Transforming growth factor-b
• ISSN: 2041-1723; 2041-1723
• DOI: 10.1038/s41467-023-41811-8

Gene expression states persist for varying lengths of time at the single-cell level, a phenomenon known as gene expression memory. When cells switch states, losing memory of their prior state, this transition can occur in the absence of genetic changes. However, we lack robust methods to find regulators of memory or track state switching. Here, we develop a lineage tracing-based technique to quantify memory and identify cells that switch states. Applied to melanoma cells without therapy, we quantify long-lived fluctuations in gene expression that are predictive of later resistance to targeted therapy. We also identify the PI3K and TGF-β pathways as state switching modulators. We propose a pretreatment model, first applying a PI3K inhibitor to modulate gene expression states, then applying targeted therapy, which leads to less resistance than targeted therapy alone. Together, we present a method for finding modulators of gene expression memory and their associated cell fates. Identifying memory and state switching in single cells remains elusive. Here, the authors develop a method, scMemorySeq, by combining cell barcoding and scRNA-seq and apply it to human melanoma cells to track lineages as they switch states between a drug-susceptible state and a state primed for drug resistance.